Sangamo Therapeutics
SGMO
#10561
Rank
ยฃ22.63 M
Marketcap
ยฃ0.05464
Share price
0.00%
Change (1 day)
-86.29%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: ยฃ22.63 Million

As of September 2026 Sangamo Therapeutics has a market cap of ยฃ22.63 Million. This makes Sangamo Therapeutics the world's 10561th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ22.63 M-78.68%
2025ยฃ0.10 B-75.05%
2024ยฃ0.42 B462.79%
2023ยฃ75.62 M-82.22%
2022ยฃ0.42 B-47.45%
2021ยฃ0.80 B-50.01%
2020ยฃ1.61 B118.75%
2019ยฃ0.74 B-19.9%
2018ยฃ0.92 B-9.89%
2017ยฃ1.02 B487.52%
2016ยฃ0.17 B-59.73%
2015ยฃ0.43 B-35.76%
2014ยฃ0.67 B28.73%
2013ยฃ0.52 B165.66%
2012ยฃ0.19 B105.78%
2011ยฃ95.87 M-50.88%
2010ยฃ0.19 B18.58%
2009ยฃ0.16 B69.17%
2008ยฃ97.3 M-63.18%
2007ยฃ0.26 B123.77%
2006ยฃ0.11 B65.28%
2005ยฃ71.44 M-9.54%
2004ยฃ78.98 M3.5%
2003ยฃ76.3 M64.3%
2002ยฃ46.44 M-70.55%
2001ยฃ0.15 B-45.5%
2000ยฃ0.28 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ473.03 B 2,089,679.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ171.59 B 757,978.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ23.63 B 104,315.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ16.27 B 71,810.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ133.97 B 591,780.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ269.16 B 1,189,007.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ23.77 B 104,953.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ9.32 B 41,086.88%๐Ÿ‡บ๐Ÿ‡ธ USA